Labcorp Holdings Inc. (LH) Stock Price & Growth Analysis

Quote Panel

Updated September 17, 2025

1W -1.30 % 1M 2.33 % 3M 5.89 % 1Y 22.88 %

Key Metrics

Market Cap
22.94B
Shares Outstanding
83.10M
Share in Float
82.83M
Dividende
2.88

Earning Date
23 Oct 2025
Price Target
276.07
Average Volume
647504
Beta
0.827

Range
209.38-283.47
Industry
Medical - Equipment & Services
Website
https://www.labcorp.com
Sector
Healthcare

Quote Panel

Updated September 17, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

18.23x

P/E Ratio

1.69x

P/S Ratio

2.70x

P/B Ratio

0.8

Debt/Equity

5.7%

Net Margin

$9.1

EPS

How LH compares to sector?

P/E Ratio

Fundamentals

Relative Strength

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$15B

316%

2026-Revenue

$17.60

515%

2026-EPS

$3B

437%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

297.00(7.58%)

Number of analyst

Last analyst upgrade/downgrade

HSBC

downgrade

Previous: Buy

2025-07-10

Now: Hold

Citigroup

upgrade

Previous: Neutral

2025-03-04

Now: Buy

Evercore ISI

upgrade

Previous: Not converted

2025-01-07

Now: Outperform

HSBC

upgrade

Previous: Not converted

2024-10-30

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.23

-28%

3.38
vs 4.68

Q4.23

-20%

3.3
vs 4.14

Q1.24

-4%

3.68
vs 3.82

Q2.24

+15%

3.94
vs 3.42

Q3.24

+4%

3.5
vs 3.38

Q4.24

+5%

3.45
vs 3.3

Q1.25

+4%

3.84
vs 3.68

Q2.25

+10%

4.35
vs 3.94

Q3.25

+18%

4.11
vs 3.5

Q4.25

+15%

3.98
vs 3.45

Sales Growth

YoY

Current

Estimates

Q3.23

-15%

3.1B vs 3.6B

Q4.23

-17%

3B vs 3.7B

Q1.24

-16%

3.2B vs 3.8B

Q2.24

+6%

3.2B vs 3B

Q3.24

+7%

3.3B vs 3.1B

Q4.24

+10%

3.3B vs 3B

Q1.25

+5%

3.3B vs 3.2B

Q2.25

+10%

3.5B vs 3.2B

Q3.25

+8%

3.6B vs 3.3B

Q4.25

+7%

3.6B vs 3.3B

Return on Equity

QoQ

Q1.23

+2%

0.02
vs 0.01

Q2.23

+2%

0.02
vs 0.02

Q3.23

+2%

0.02
vs 0.02

Q4.23

-2%

-0.02
vs 0.02

Q1.24

+3%

0.03
vs -0.02

Q2.24

+3%

0.03
vs 0.03

Q3.24

+2%

0.02
vs 0.03

Q4.24

+2%

0.02
vs 0.02

Q1.25

+3%

0.03
vs 0.02

Q2.25

+3%

0.03
vs 0.03

Institutionnal Ownership

QoQ

Q1.23

963

963
vs 997

-3%

Q2.23

957

957
vs 963

-1%

Q3.23

904

904
vs 957

-6%

Q4.23

977

977
vs 904

Q1.24

949

949
vs 977

-3%

Q2.24

869

869
vs 949

-8%

Q3.24

934

934
vs 869

Q4.24

933

933
vs 934

Q1.25

966

966
vs 933

Q2.25

954

954
vs 966

-1%

Earnings Growth

YoY

Current

Estimates

Q3.23

-28%

3.38
vs 4.68

Q4.23

-20%

3.3
vs 4.14

Q1.24

-4%

3.68
vs 3.82

Q2.24

+15%

3.94
vs 3.42

Q3.24

+4%

3.5
vs 3.38

Q4.24

+5%

3.45
vs 3.3

Q1.25

+4%

3.84
vs 3.68

Q2.25

+10%

4.35
vs 3.94

Q3.25

+18%

4.11
vs 3.5

Q4.25

+15%

3.98
vs 3.45

Sales Growth

YoY

Current

Estimates

Q3.23

-15%

3.1B vs 3.6B

Q4.23

-17%

3B vs 3.7B

Q1.24

-16%

3.2B vs 3.8B

Q2.24

+6%

3.2B vs 3B

Q3.24

+7%

3.3B vs 3.1B

Q4.24

+10%

3.3B vs 3B

Q1.25

+5%

3.3B vs 3.2B

Q2.25

+10%

3.5B vs 3.2B

Q3.25

+8%

3.6B vs 3.3B

Q4.25

+7%

3.6B vs 3.3B

Return on Equity

QoQ

Q1.23

+2%

0.02
vs 0.01

Q2.23

+2%

0.02
vs 0.02

Q3.23

+2%

0.02
vs 0.02

Q4.23

-2%

-0.02
vs 0.02

Q1.24

+3%

0.03
vs -0.02

Q2.24

+3%

0.03
vs 0.03

Q3.24

+2%

0.02
vs 0.03

Q4.24

+2%

0.02
vs 0.02

Q1.25

+3%

0.03
vs 0.02

Q2.25

+3%

0.03
vs 0.03

Institutionnal Ownership

QoQ

Q1.23

963

963
vs 997

-3%

Q2.23

957

957
vs 963

-1%

Q3.23

904

904
vs 957

-6%

Q4.23

977

977
vs 904

Q1.24

949

949
vs 977

-3%

Q2.24

869

869
vs 949

-8%

Q3.24

934

934
vs 869

Q4.24

933

933
vs 934

Q1.25

966

966
vs 933

Q2.25

954

954
vs 966

-1%

Earnings Growth

Forecast

$15B

316%

2026-Revenue

$17.60

515%

2026-EPS

$3B

437%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

297.00(7.58%)

Number of analyst

Last analyst upgrade/downgrade

HSBC

downgrade

Previous: Buy

2025-07-10

Now: Hold

Citigroup

upgrade

Previous: Neutral

2025-03-04

Now: Buy

Evercore ISI

upgrade

Previous: Not converted

2025-01-07

Now: Outperform

HSBC

upgrade

Previous: Not converted

2024-10-30

Now: Buy

Company Description

276.07USD

18.23x

1.69x

2.70x

0.8

5.7%

$9.1

$15B

$17.60

$3B

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

$15B

$17.60

$3B

Company Description

276.07USD

18.23x

1.69x

2.70x

0.8

5.7%

$9.1